- Report
- February 2023
- 50 Pages
Global
From €3616EUR$3,950USD£3,073GBP
- Report
- January 2022
- 90 Pages
Global
From €1831EUR$2,000USD£1,556GBP
- Report
- January 2022
- 70 Pages
Global
From €915EUR$1,000USD£778GBP
- Report
- February 2024
- 180 Pages
Global
From €4549EUR$4,969USD£3,866GBP
- Report
- November 2023
- 160 Pages
Global
From €3295EUR$3,599USD£2,800GBP
- Report
- June 2023
- 120 Pages
Asia Pacific
From €3542EUR$3,869USD£3,010GBP
- Report
- May 2023
- 160 Pages
Global
From €4530EUR$4,949USD£3,850GBP
- Report
- May 2023
- 147 Pages
Global
From €4530EUR$4,949USD£3,850GBP
- Report
- March 2023
- 147 Pages
Global
From €4530EUR$4,949USD£3,850GBP
- Report
- March 2023
- 147 Pages
Global
From €4530EUR$4,949USD£3,850GBP
- Report
- May 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- August 2023
- 145 Pages
Global
From €2884EUR$3,150USD£2,451GBP
- Report
- March 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- March 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- February 2024
- 125 Pages
Asia Pacific
From €3158EUR$3,450USD£2,684GBP
- Report
- October 2022
- 177 Pages
From €3158EUR$3,450USD£2,684GBP
- Report
- October 2022
- 174 Pages
North America
From €3158EUR$3,450USD£2,684GBP
- Report
- October 2022
- 181 Pages
Africa, Middle East
From €3158EUR$3,450USD£2,684GBP
- Report
- October 2022
- 202 Pages
Europe
From €3158EUR$3,450USD£2,684GBP
- Report
- October 2022
- 205 Pages
Asia Pacific
From €3158EUR$3,450USD£2,684GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more